Moleculin Biotech, Inc. (MBRX) Form 10-Q Quarterly Reports
Moleculin Biotech, Inc. (MBRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MBRX
CIK: 1659617
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerRobert Holt
Audit LocationFt. Lauderdale, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001437749-26-032866 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001437749-26-032865 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001437749-26-032864 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-16 | FORM 8-K | 0001437749-26-032762 | View SEC Doc Filr Page |
| S-8 | 2026-10-15 | — | FORM S-8 | 0001437749-26-032730 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-09 | FORM 8-K | 0001437749-26-032455 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | FORM 8-K | 0001437749-26-031978 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | FORM 8-K | 0001437749-26-031419 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | FORM 8-K | 0001437749-26-031280 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-25 | FORM 8-K | 0001437749-26-031199 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | FORM 8-K | 0001437749-26-031005 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-15 | FORM 8-K | 0001437749-26-030757 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | FORM 8-K | 0001437749-26-030315 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | FORM 8-K | 0001437749-26-029336 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-25 | — | SCHEDULE 13D Filing | 0001437749-26-028927 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-25 | — | SCHEDULE 13D Filing | 0001437749-26-028926 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-24 | — | FORM DEFA14A | 0001437749-26-028842 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-24 | 2026-10-09 | FORM DEF 14A | 0001437749-26-028835 | View SEC Doc Filr Page |
| 424B5 | 2026-08-21 | — | FORM 424B5 | 0001437749-26-028751 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-14 | 2026-10-09 | FORM PRE 14A | 0001437749-26-028049 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001437749-26-027835 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001437749-26-027688 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001649553-26-000082 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0001213900-26-086246 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001437749-26-025929 | View SEC Doc Filr Page |